title: Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice.
abstract: G-protein subunit Galphai2-deficient mice spontaneously develop an inflammatory bowel disease that clinically and histopathologically resembles ulcerative colitis in humans. The aim of this study was to determine whether immunological changes precede the development of colitis in Galphai2-deficient mice. Therefore, Galphai2-deficient mice with no clinical or histopathological signs of colitis were compared with Galphai2-deficient mice with established colitis and wild-type animals, concerning immunological parameters. Healthy Galphai2-deficient mice displayed an increased frequency of CD4+ T cells and a decreased frequency of CD19+ B lymphocytes in the intestinal mucosa compared with control mice. The CD4+ population was characterized by a memory phenotype, i.e. increased expression of CD44 and decreased expression of CD45RB and CD62L, as well as increased expression of the mucosal homing receptors integrins alpha4beta7 and alphaEbeta7. Production of pro-inflammatory cytokines, interleukin (IL)-1beta and interferon (IFN)-gamma, were increased in Galphai2-deficient mice before clinical signs of disease were evident. In addition, total immunoglobulin (Ig)G and IgA levels in large intestinal secretions were increased significantly compared with wild-type mice, and antibodies specific for the normal intestinal flora in large intestinal secretions were present in Galphai2-deficient mice several weeks before the onset of colitis. In contrast, antibodies against tropomyosin, a putative autoantigen in human ulcerative colitis, were not found in Galphai2-deficient mice before the onset of colitis, although they were present in animals with established disease. In conclusion, activation of the intestinal immune system precedes histopathological and clinical signs of inflammation in Galphai2-deficient mice, suggesting that immune abnormalities play an important role in the induction of colitis.
authors.affiliation: Department of Medical Microbiology and Immunology, Göteborg University, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Ohman
authors.forename: L
authors.initials: L
authors.lastname: Franzén
authors.forename: U
authors.initials: U
authors.lastname: Rudolph
authors.forename: G R
authors.initials: GR
authors.lastname: Harriman
authors.forename: E
authors.initials: E
authors.lastname: Hultgren Hörnquist
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D003092:Colitis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D016207:Cytokines / Q000096:biosynthesis; D005260:Female; D019206:GTP-Binding Protein alpha Subunits, Gi-Go / Q000502:physiology*; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007413:Intestinal Mucosa / Q000276:immunology*; D008297:Male; D051379:Mice; D009504:Neutrophils / Q000502:physiology; D014335:Tropomyosin / Q000276:immunology; D015431:Weight Loss
chemical_list: D000907:Antibodies, Bacterial; D001323:Autoantibodies; D016207:Cytokines; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D014335:Tropomyosin; D019206:GTP-Binding Protein alpha Subunits, Gi-Go